{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:50Z","timestamp":1793060030639,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T00:00:00Z","timestamp":1397520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10067-014-2589-z","type":"journal-article","created":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T02:20:01Z","timestamp":1397442001000},"page":"1141-1143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Paradoxical mucocutaneous flare in a case of Beh\u00e7et\u2019s disease treated with tocilizumab"],"prefix":"10.1007","volume":"34","author":[{"given":"Luca","family":"Cantarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Coladonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orso Maria","family":"Lucherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lapadula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,15]]},"reference":[{"key":"2589_CR1","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00018-003-2333-3","volume":"60","author":"M Zierhut","year":"2003","unstructured":"Zierhut M, Mizuki N, Ohno S, Inoko H, G\u00fcl A, Ono\u00e9 K et al (2003) Immunology and functional genomics of Beh\u00e7et\u2019s disease. Cell Mol Life Sci 60:1903\u20131922","journal-title":"Cell Mol Life Sci"},{"key":"2589_CR2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G (1999) Beh\u00e7et\u2019s disease. N Engl J Med 341:1284\u20131291","journal-title":"N Engl J Med"},{"key":"2589_CR3","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D, McDermott MF (2006) A proposed classification of the immunological diseases. PLoS Med 3:e297","journal-title":"PLoS Med"},{"key":"2589_CR4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/BOR.0b013e3283368099","volume":"22","author":"I Kotter","year":"2010","unstructured":"Kotter I, Hamuryudan V, Ozturk ZE, Yazici H (2010) Interferon therapy in rheumatic diseases: state-of-the-art 2010. Curr Opin Rheumatol 22:278\u2013283","journal-title":"Curr Opin Rheumatol"},{"key":"2589_CR5","first-page":"S115","volume":"30","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Vitale A, Borri M, Galeazzi M, Franceschini R (2012) Successful use of canakinumab in a patient with resistant Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 30:S115","journal-title":"Clin Exp Rheumatol"},{"key":"2589_CR6","doi-asserted-by":"crossref","unstructured":"Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R, et al. (2013) Anakinra treatment in drug-resistant Beh\u00e7et\u2019s disease: a case series. Clin Rheumatol [Epub ahead of print].","DOI":"10.1007\/s10067-013-2443-8"},{"key":"2589_CR7","first-page":"532","volume":"23","author":"E Alpsoy","year":"2005","unstructured":"Alpsoy E (2005) Beh\u00e7et\u2019s disease: treatment of mucocutaneous lesions. Clin Exp Rheumatol 23:532\u2013539","journal-title":"Clin Exp Rheumatol"},{"key":"2589_CR8","first-page":"S45","volume":"19","author":"R Tun\u00e7","year":"2001","unstructured":"Tun\u00e7 R, Uluhan A, Meliko\u011flu M, Ozyazgan Y, Ozdo\u011fan H, Yazici H (2001) A reassessment of the International Study Group criteria for the diagnosis (classification) of Beh\u00e7et\u2019s syndrome. Clin Exp Rheumatol 19:S45\u2013S47","journal-title":"Clin Exp Rheumatol"},{"key":"2589_CR9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/s10165-011-0497-5","volume":"22","author":"T Hirano","year":"2012","unstructured":"Hirano T, Ohguro N, Hohki S, Hagihara K, Shima Y, Narazaki M et al (2012) A case of Beh\u00e7et\u2019s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Mod Rheumatol 22:298\u2013302","journal-title":"Mod Rheumatol"},{"key":"2589_CR10","first-page":"S73","volume":"30","author":"P Urbaniak","year":"2012","unstructured":"Urbaniak P, Hasler P, Kretzschmar S (2012) Refractory neuro-Beh\u00e7et treated by tocilizumab: a case report. Clin Exp Rheumatol 30:S73\u2013S75","journal-title":"Clin Exp Rheumatol"},{"key":"2589_CR11","doi-asserted-by":"crossref","unstructured":"Caso F, Iaccarino L, Bettio S, Ometto F, Costa L, Punzi L, et al. (2013) Refractory pemphigus foliaceus and Beh\u00e7et\u2019s disease successfully treated with tocilizumab. Immunol Res 56:390\u2013397","DOI":"10.1007\/s12026-013-8411-1"},{"key":"2589_CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10238-004-0033-4","volume":"4","author":"M Suzuki Kurokawa","year":"2004","unstructured":"Suzuki Kurokawa M, Suzuki N (2004) Behcet\u2019s disease. Clin Exp Med 4:10\u201320","journal-title":"Clin Exp Med"},{"key":"2589_CR13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2011.12.005","volume":"11","author":"ZY Zhou","year":"2012","unstructured":"Zhou ZY, Chen SL, Shen N, Lu Y (2012) Cytokines and Beh\u00e7et\u2019s disease. Autoimmun Rev 11:699\u2013704","journal-title":"Autoimmun Rev"},{"key":"2589_CR14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.23345","volume":"59","author":"N Pipitone","year":"2008","unstructured":"Pipitone N, Olivieri I, Padula A, D\u2019angelo S, Nigro A, Zuccoli G et al (2008) Infliximab for the treatment of neuro-Beh\u00e7et\u2019s disease: a case series and review of the literature. Arthritis Rheum 59:285\u2013290","journal-title":"Arthritis Rheum"},{"key":"2589_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","volume":"41","author":"A Arida","year":"2011","unstructured":"Arida A, Fragiadaki K, Giavri E, Sfikakis PP (2011) Anti-TNF agents for Beh\u00e7et\u2019s disease: analysis of published data on 369 patients. Semin Arthritis Rheum 41:61\u201370","journal-title":"Semin Arthritis Rheum"},{"key":"2589_CR16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/039463200902200235","volume":"22","author":"L Cantarini","year":"2009","unstructured":"Cantarini L, Tinazzi I, Caramaschi P, Bellisai F, Brogna A, Galeazzi M (2009) Safety and efficacy of etanercept in children with juvenile-onset Behcet\u2019s disease. Int J Immunopathol Pharmacol 22:551\u2013555","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2589_CR17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.2006.064279","volume":"66","author":"JA Laar van","year":"2007","unstructured":"van Laar JA, Missotten T, van Daele PL, Jamnitski A, Baarsma GS, van Hagen PM (2007) Adalimumab: a new modality for Beh\u00e7et\u2019s disease? Ann Rheum Dis 66:565\u2013566","journal-title":"Ann Rheum Dis"},{"key":"2589_CR18","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.21233","volume":"52","author":"PP Sfikakis","year":"2005","unstructured":"Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A (2005) Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum 52:2513\u20132518","journal-title":"Arthritis Rheum"},{"key":"2589_CR19","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/rheumatology\/ket130","volume":"52","author":"AP Diamantopoulos","year":"2013","unstructured":"Diamantopoulos AP, Hatemi G (2013) Lack of efficacy of tocilizumab in mucocutaneous Behcet\u2019s syndrome: report of two cases. Rheumatology (Oxford) 52:1923\u20131924","journal-title":"Rheumatology (Oxford)"},{"key":"2589_CR20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clineuro.2011.10.024","volume":"114","author":"LS Shapiro","year":"2012","unstructured":"Shapiro LS, Farrell J, Borhani Haghighi A (2012) Tocilizumab treatment for neuro-Behcet\u2019s disease, the first report. Clin Neurol Neurosurg 114:297\u2013298","journal-title":"Clin Neurol Neurosurg"},{"key":"2589_CR21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1189\/jlb.0802397","volume":"73","author":"ZQ Lin","year":"2003","unstructured":"Lin ZQ, Kondo T, Ishida Y, Takayasu T, Mukaida N (2003) Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol 73:713\u2013721","journal-title":"J Leukoc Biol"},{"key":"2589_CR22","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.274.5291.1379","volume":"274","author":"DE Cressman","year":"1996","unstructured":"Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V et al (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379\u20131383","journal-title":"Science"},{"key":"2589_CR23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/1547691X.2012.707700","volume":"10","author":"EG Lee","year":"2013","unstructured":"Lee EG, Mickle-Kawar BM, Gallucci RM (2013) IL-6 deficiency exacerbates skin inflammation in a murine model of irritant dermatitis. J Immunotoxicol 10:192\u2013200","journal-title":"J Immunotoxicol"},{"key":"2589_CR24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0305-4179(95)00005-4","volume":"21","author":"I Ono","year":"1995","unstructured":"Ono I, Gunji H, Zhang JZ, Maruyama K, Kaneko F (1995) A study of cytokines in burn blister fluid related to wound healing. Burns 21:352\u2013355","journal-title":"Burns"},{"key":"2589_CR25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.mehy.2008.01.011","volume":"71","author":"A Borhani Haghighi","year":"2008","unstructured":"Borhani Haghighi A, Safari A (2008) Tocilizumab may be a potential addition to our weapons against neuro-Beh\u00e7et\u2019s disease. Med Hypotheses 71:156\u2013157","journal-title":"Med Hypotheses"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2589-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2589-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2589-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T09:50:24Z","timestamp":1565344224000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2589-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,15]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2589"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2589-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,15]]}}}